Hostname: page-component-84b7d79bbc-lrf7s Total loading time: 0 Render date: 2024-07-26T04:59:59.907Z Has data issue: false hasContentIssue false
  • English
  • Français

Antinuclear Antibody Factors and Nuclear Staining in Mothers of Children Affected with Down's Syndrome

Published online by Cambridge University Press:  01 August 2014

Freddie L. Pollard ,
Steven Zsako ,
Margaret A. Kelsall  and
Arnold R. Kaplan
Freddie L. Pollard*
Affiliation:
Laboratories of Cytology and of Medical Genetics, Cleveland Psychiatric Institute, Cleveland, Ohio; and Department of Medicine, Euclid Clinic Foundation, Euclid, Ohio
Steven Zsako
Affiliation:
Laboratories of Cytology and of Medical Genetics, Cleveland Psychiatric Institute, Cleveland, Ohio; and Department of Medicine, Euclid Clinic Foundation, Euclid, Ohio
Margaret A. Kelsall
Affiliation:
Laboratories of Cytology and of Medical Genetics, Cleveland Psychiatric Institute, Cleveland, Ohio; and Department of Medicine, Euclid Clinic Foundation, Euclid, Ohio
Arnold R. Kaplan
Affiliation:
Laboratories of Cytology and of Medical Genetics, Cleveland Psychiatric Institute, Cleveland, Ohio; and Department of Medicine, Euclid Clinic Foundation, Euclid, Ohio
*
Laboratory of Cytology, Cleveland Psychiatric Institute, 1708 Aiken Avenue, Cleveland, Ohio 44109, USA

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Sera from 50 mothers of G1-trisomy affected children and from 50 age-matched mothers, whose offspring included no chromosomal-aneuploidy affected children, were tested for presence of antinuclear antibody factors and nuclear staining with human squamous epithelium and with mouse liver. Consistently, more of the mothers of G1-trisomy affected children included positive findings in both tests, compared to the age-matched mothers.

Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 19 , Issue 4 , October 1970 , pp. 529 - 533
Copyright
Copyright © The International Society for Twin Studies 1970

References

Bauer, J. D., Ackermann, P. G., Toro, G. (1968). Bray's Clinical Laboratory Methods. 7th Ed. C. V. Mosby, St. Louis, Mo.Google Scholar
Beutner, E. H., Witebsky, E. (1962). Studies on organ specificity. XIV. Immunonuorescent studies of thyroid reactive autoantibodies in human sera. J. Immun., 88: 462.CrossRefGoogle Scholar
Burgio, G. R., Severi, F., Rossoni, R., Vaccaro, R. (1965). Mongolism and thyroid autoimmunity. Lancet, 1: 166.Google Scholar
Coons, A. H. (1956). In Dannielli, J. F.: General Cytochemical Methods. Academic Press, New York.Google Scholar
Fialkow, P. J. (1964). Autoimmunity: a predisposing factor to chromosomal aberrations? Lancet, 1: 474.Google Scholar
Fialkow, P. J. (1966). Autoimmunity and chromosomal aberrations. Amer. J. Hum. Genet., 18: 93.Google Scholar
Fialkow, P. J., Uchida, I. A. (1968). Autoantibodies in Down's syndrome and gonadal dysgenesis. Ann. N.Y. Acad. Sci., 155: 759.Google Scholar
Friou, G. J. (1962). Fluorescent spot test for anti-nuclear antibodies. Arthritis Rheum., 5: 407.CrossRefGoogle ScholarPubMed
Hasker, J., Mackay, I. R., Miller, J. J. (1965). The incidence of “antinuclear factor” in human disease. Aust. Ann. Med., 14: 96.Google Scholar
Marmont, A. M., Damasio, E. E., Bertorello, C., Rossi, F. (1967). Studies on the antiperinuclear factor. Arthritis Rheum., 10: 117.CrossRefGoogle ScholarPubMed
Ritchie, R. F. (1967). The clinical significance of titered antinuclear antibodies. Arthritis Rheum., 10: 544.CrossRefGoogle ScholarPubMed
Seligmann, M., Cannat, A., Hamard, M. (1965). Studies on antinuclear antibodies. Ann. N. Y. Acad. Sci., 124: 816.Google Scholar
Svec, K. H., Blair, J. D., Kaplan, M. H. (1967). Immuno-pathologic studies of systemic lupus erythematosus. J. Clin. Invest., 46: 558.Google Scholar
Vallotin, M. B., Forbes, A. P. (1966). Autoimmunity in gonadal dysgenesis and Klinefelter's syndrome. Lancet, 2: 264.Google Scholar